Recent News

2015 Newsletter
View our year in review with a special section highlighting Aziz Sancar's Nobel Prize.
Grad student Andrew Monteith receives a 2016 GEAB Impact Award
Sponsored by UNC-Chapel Hill Graduate School’s Graduate Education Advancement Board, the Impact Awards recognize graduate students whose research provides special benefits to the citizens of North Carolina. Congrats to Andrew!
The Man Behind the Nobel Prize
In this video, learn more about Aziz Sancar, the Sarah Graham Kenan Professor of Biochemistry and Biophysics and Nobel Prize Laureate in Chemisty for 2015.
Motion Pictures of Micro Anatomy
Qi Zhang, PhD earns a 2015 Jefferson-Pilot Award for his groundbreaking techniques that allow him to create videos of the tiniest bits of the stuff that make us human.
Grad student Andrew Monteith receives his PhD
Andrew successfully defended his dissertation and received his PhD on November 20, 2015.
Aziz Sancar receives 2015 Nobel Prize in Chemistry
Deepak Jha receives a 2013 Lineberger Fellow award
Congratulations to Deepak Jha, former graduate student in the Brian Strahl lab, who received a 2013 Lineberger Predoctoral Fellow Award in the Basic Sciences.
UNC researchers earn prestigious Keck award for cell cycle map
The labs of Jean Cook, PhD, and Jeremy Purvis, PhD, will develop the first-ever interactive molecular model of a crucial cellular process that controls healthy growth and diseases such as cancer.
UNC Lineberger team finds possible strategy to overcome radiation therapy resistance acquired by cancer cells
In a new study published in the Cell Press journal "Chemistry & Biology", researchers in the Chen lab share a discovery that could lead to a new strategy for sensitizing radiation-resistant cancer cells to the treatment.
Potential drug target identified for aggressive breast cancer type
In a new pre-clinical study published today in the journal Breast Cancer Research and Treatment, researchers from the Parise lab show they can exploit cancer’s reliance on a particular protein to help fight triple negative breast cancer. They believe the protein could be a potential new drug target.